Shares of Apollo Hospitals Enterprise are expected to remain in focus today after the healthcare major reported a strong set of Q4FY26 earnings, driven by healthy growth in revenue and improvement in operating margins.
The company posted a consolidated net profit of ₹547.2 crore for the March quarter, registering a growth of 33% compared to ₹412 crore reported in the same quarter last year. The sharp rise in profitability was supported by higher revenues and improved operational efficiency across its hospital and healthcare businesses.
Revenue from operations during the quarter rose 18.1% year-on-year to ₹6,606 crore, compared to ₹5,592 crore in the corresponding period of the previous financial year, reflecting strong demand across hospital services, pharmacies, and digital health segments.
Apollo Hospitals also reported a robust operational performance during the quarter. EBITDA increased 31.3% YoY to ₹1,011 crore against ₹770 crore in the year-ago period. EBITDA margin improved significantly to 15.3% from 13.8% last year, indicating better cost management and higher contribution from core healthcare operations.
The board of directors has also recommended a dividend of ₹10 per equity share for the financial year ended March 2026, subject to shareholder approval at the upcoming annual general meeting.